CDERLearn

Search General Courses

Search Industry Courses

---

Continuing Education (CE) Credits Update

[4/1/2025] The FDA's accredited Continuing Education program is unable to process CE applications or CE credits at this time. We apologize for the inconvenience.

Use filters and search box to find resources

Advanced search (combine topic and search terms)

Topic Artificial IntelligenceBiosimilarsCancer DrugsCannabidiolCompoundingCOVID-19Drug DevelopmentDrug Regulatory ProcessDrug SafetyEspañolGeneric DrugsHealth FraudIND/Expanded AccessMedWatchMinority HealthOpioidsOTC Drug RegulationsRare DiseasesSunscreenWomen's Health

CE (Continuing Education) Credits YesNo

Description	Topic	CE	Credits
FDA approval of Bizengri (zenocutuzumab-zbco)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Overview of our role regulating and approving drugs	Drug Development; Drug Regulatory Process; Drug Safety	No	0
7 Things to Know About Drug Shortage Management	Drug Regulatory Process; Drug Safety	No	0
FDA approval of Enhertu	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA’s Regulation of Dietary Supplements with Dr. Cara Welch	Health Fraud	Yes	0.5
The Need for Artificial Intelligence in Pharmacovigilance with Dr. Robert Ball	Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence	No	0
Antibiotics: Know When and How to Use Them	Drug Safety	No	0
FDA approval of Tecelra (afamitresgene autoleucel)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Understanding Drug Recalls with Dr. Ileana Elder	Drug Regulatory Process; Drug Safety	No	0
Resource Guide for Teaching Faculty	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim	Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs	No	0
FDA approval of Retevmo	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Accidental Exposures to Fentanyl Patches Continue to Be Deadly to Children	Drug Regulatory Process; Drug Safety; Opioids	No	0
Should You Give Kids Medicine for Coughs and Colds?	Drug Regulatory Process; Drug Safety; OTC Drug Regulations	No	0
What Does FDA Approve? Part 2	Drug Safety; MedWatch	No	0
Is It Really 'FDA Approved'?	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	No	0
10 Facts about What FDA Does and Does Not Approve	CBD; Compounding; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Sunscreen: How to Help Protect Your Skin from the Sun	Sunscreen	No	0
Facts about Sunscreen	Sunscreen	No	0
Medicamentos	Drug Development; Drug Regulatory Process; Drug Safety; Español	No	0
Datos acerca de los medicamentos genéricos	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español	No	0
Hechos Sobre Los Medicamentos Genericos	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español	No	0
Medicamentos Genéricos: Preguntas y Respuestas	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español	No	0
2024 PDA/ FDA Joint Regulatory Conference	Drug Development; Drug Regulatory Process; Drug Safety	No	0
Complex Innovative Trial Design Meeting Program	Case Study; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Ojemda (tovorafenib)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Conversations on Cancer—Strength in Numbers: Increasing Cancer Awareness While Decreasing Disparities	Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety; Minority Health	No	0
Conversations on Cancer: ODAC Chronicles - the Past, Present, and Future of Oncology Advisory Committees	Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety	No	0
Considerations for Drug Products that Contain Nanomaterials	Drug Regulatory Process; Drug Development; Drug Safety	No	0
Compounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Opioid Use Disorder, New Biosimilar, Black Family Cancer Awareness Week, & more	Biosimilars; Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety; Minority Health, Opioids	No	0
The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad	Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence	Yes	0.5
Practitioners’ Guide for Improving Oral Anticoagulant Use	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
14th Annual Sentinel Initiative Public Workshop	COVID-19; Drug Regulatory Process; Drug Development; Drug Safety	No	0
6 Tip-Offs to Rip-Offs: Don't Fall for Health Fraud Scams	Drug Safety; Health Fraud	No	0
Accelerating Access to Critical Therapies for ALS	Drug Development; Drug Regulatory Process	No	0
Accelerating Rare disease Cures (ARC) Program	Drug Development; Drug Regulatory Process; Rare Diseases	No	0
Achieving Data Quality and Integrity in Maximum Containment Laboratories	Drug Development; Drug Regulatory Process; Drug Safety	No	0
Advancing Generic Drug Development: Translating Science to Approval 2023	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
Advancing Regulatory Science at FDA	Drug Development; Drug Regulatory Process	No	0
Advancing Transparency and Regulatory Science Activities on the Risk Evaluation and Mitigation Strategy (REMS)	Drug Regulatory Process; Drug Development; Drug Safety	Yes	1
Adverse Events Associated with Compounded Drugs from Outsourcing Facilities	Case Study; Compounding; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch	No	0
Airflow	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	Yes	4
Application of Artificial Intelligence and Machine Learning for Precision Medicine	Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence	No	0
Are you on a biologic medication? What you need to know about biosimilar treatment options	Biosimilars	No	0
Areas of Customer Need for Outsourcing Facility Products	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Aseptic Process Simulations (Media Fills)	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	Yes	2
BeSafeRx: Your Source for Online Pharmacy Information	Drug Safety: Health Fraud	No	0
Biological Products, Biosimilars Products, and Interchangeable Biosimilar Products	Biosimilars; Drug Regulatory Process; Drug Development	No	0
Biosimilar and Interchangeable Biologics: More Treatment Choices	Biosimilars	No	0
Biosimilar Basics	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
Biosimilar Basics for Patients	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
Biosimilar Manufacturing and Variation	Biosimilars; Drug Regulatory Process; Drug Development	No	0
Biosimilar Medications - What Health Care Providers Need to Know	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
Biosimilar Medications - What Patients Need to Know	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
Biosimilar Regulatory Approval Pathway	Biosimilars; Drug Regulatory Process; Drug Development	No	0
Biosimilares: Lo que los pacientes con diabetes deben saber	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español	No	0
Biosimilares: Lo que los pacientes deben saber	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español	No	0
Biosimilars 101: A Primer for Your Practice	Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women's Health	Yes	0.25
Biosimilars 102: Interchangeability, Extrapolation, and Immunogenicity - A Regulatory Process Primer (medscape.org)	Biosimilars; Drug Regulatory Process; Drug Development	Yes	0.25
Biosimilars Basics Infographic	Biosimilars; Generic Drugs	No	0
Biosimilars Curriculum Materials for Health Care Degree Programs	Biosimilars; Case Study; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
Biosimilars in the Real World: Perspectives for Staying Within the Scope of Care	Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch	Yes	0.5
Biosimilars Level 1: Foundational Concepts	Biosimilars; Case Study Drug Regulatory Process; Drug Development	No	0
Biosimilars Level 2: Regulatory and Scientific Concepts	Case Study	No	0
Biosimilars Multimedia Education Materials	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Biosimilars Overview for Health Care Professionals	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Biosimilars Patient Materials	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
Biosimilars Resources	Biosimilars; Case Study; Drug Regulatory Process; Drug Development	No	0
Biosimilars Videos	Drug Development; Biosimilars;  Drug Regulatory Process	No	0
Biosimilars: A Review of Scientific, Regulatory, and Clinical Considerations for Health Care Providers	Biosimilars; Drug Regulatory Process; Drug Development	Yes	1
Biosimilars: Are they the same quality?	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
Biosimilars: What Patients Need to Know	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
Biosimilars: What Patients With Diabetes Need To Know	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
Biosimillars Health Care Provider Materials	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
Bridging Efficacy and Safety to the Obese	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access; MedWatch; Women's Health	No	0
Bringing Clinical Research to Patients	Drug Regulatory Process; Drug Development; Drug Safety	Yes	1
Cannabis and Cannabis-Derived Products – For Healthcare Practitioners	Drug Regulatory Process; Drug Development; Drug Safety; Cannabidiol	Yes	1
CDER Conversation: Improving Medication Adherence and Patient Experience by Researching Patient Perceptions of Generic Drug	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
CDER Webinars	Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND/Expanded Access; Cancer Drugs	No	0
CDER’s Emerging Drug Safety Technology Meeting Program	Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence	No	0
Cleanroom In-person Course	Compounding; Drug Regulatory Process; Drug Development	Yes	13.75
Clinical Trial Basics	Drug Regulatory Process; Drug Development; Drug Safety; IND/Expanded Access; Women's Health	No	0
Clinical Trial Basics with Dr. Robert Temple	Drug Regulatory Process; Drug Development; Drug Safety; IND/Expanded Access; Women's Health	Yes	0.5
Compounding Outsourcing Facilities Annual Study	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Compounding Quality Center of Excellence Annual Conference 2023	Compounding, COVID-19, Drug Development, Drug Regulatory Process, Drug Safety	No	0
Compounding Quality Center of Excellence Virtual Conference	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Conceptos ba¡sicos sobre los biosimilares	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español	No	0
Conversation on Paxlovid with Dr. John Farley	COVID-19; Drug Regulatory Process; Drug Development; Drug Safety	Yes	0.5
Conversations on Cancer, Black History Month Program: Real Talk: Our Stories as Black Oncologists at the FDA	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety, Minority Health	No	0
Conversations on Cancer: "What's on the Horizon: Future of Cancer Care"	Cancer Drugs	No	0
Conversations on Cancer: Bringing Innovation to People Facing Cancer	Cancer Drugs	No	0
Conversations on Cancer: Cancer Disparities in Appalachia	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Conversations on Cancer: Cancer Misinformation: Truth or Consequences	Cancer Drugs, Drug Development, Drug Regulatory Process, Drug Safety	No	0
Conversations on Cancer: How Biotech Built a Blockbuster Cancer Drug	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Conversations on Cancer: Living with Metastatic Breast Cancer	Cancer Drugs	No	0
Conversations on Cancer: National Black Family Cancer Awareness Week, Engaging the Generations	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety, Minority Health	No	0
Conversations on Cancer: Seasons of Change: Oncology Careers	Cancer Drugs	No	0
Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito	Case Study; COVID-19; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch	Yes	0.5
Development and U.S. Regulation of Preventative Vaccines	Drug Regulatory Process; Drug Development	Yes	1
Drug Approval Case Studies	Case Study; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access	No	0
Drug Information Soundcast in Clinical Oncology (D.I.S.C.O)	Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women's Health	No	0
Drug Shortages with CDR Emily Thakur	COVID-19; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Drug Shortages: Root Causes and Potential Solutions	Drug Regulatory Process; Drug Development	Yes	1
Environmental Monitoring In-person Course	Compounding; Drug Regulatory Process; Drug Development	Yes	15.25
Equity of Voices video series	Case Study; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch	No	0
Expanded Access with Dr. Jacqueline Corrigan-Curay	Drug Development; Drug Regulatory Process; Drug Safety; IND/Expanded Access	Yes	0.5
FDA 101: An Overview of FDA's Regulatory Review and Research Activities	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access; OTC Drug Regulations; Women's Health	No	0
FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)	Disease States; Drug Development; Drug Regulatory Process	Yes	0.5
FDA approval of Augtyro (repotrectinib)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Epkinly (epcoritamab-bysp)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Fruzaqla (fruquintinib)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Jemperli (dostarlimab-gxly)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Keytruda (pembrolizumab)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Lynparza (Olaparib)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of OGSIVEO (nirogacestat)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Omisirge (omidubicel-onlv)	Cancer Drugs, Drug Development, Drug Regulatory Process, Drug Safety	No	0
FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Polivy (polatuzumab vedotin-piiq)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) for pediatric patients with low-grade glioma with a BRAF V600E mutation	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Tibsovo (ivosidenib)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approval of Trodelvy (sacituzumab govitecan-hziy)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health	No	0
FDA approval of Verzenio (abemaciclib)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health	No	0
FDA approval of Zynyz (retifanlimab-dlwr)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approvals of Jaypirca (pirtobrutinib) and Orserdu (elacestrant)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health	No	0
FDA approvals of Talvey and Elrexfio	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA approvals of Tukysa (tucatinib)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA D.I.S.C.O. Burst Edition: Retevmo (selpercatinib)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA Drug Info Rounds	Drug Safety; MedWatch; IND/Expanded Access; Drug Development; Drug Regulatory Process; Generic Drugs	No	0
FDA Drug Safety Podcasts	Drug Safety	Yes	0.5
FDA Grand Rounds	COVID-19; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; Biosimilars; IND/Expanded Access; Cancer Drugs; Women's Health	No	0
FDA Health Playbook	Drug Safety; OTC Drug Regulations; MedWatch; Opioids	No	0
FDA Insight	Compounding; COVID-19; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Opioids; Women's Health; OTC Drug Regulations	No	0
FDA MedWatch and Patient Safety	MedWatch; Drug Safety	No	0
FDA Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Select Dosages for Combination Therapies and New Indications	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; IND/Expanded Access	No	0
FDA Overview of Biosimilar Products	Biosimilars;Drug Regulatory Process; Drug Development	No	0
FDA Rare Disease Day 2023	Drug Development; Drug Regulatory Process; Drug Safety; Rare Diseases	No	0
FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds	Drug Development; Drug Regulatory Process; Drug Safety; IND/Expanded Access; Cannabidiol	No	0
FDA Review and Approval Process for Biosimilar Medications	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; OTC Drug Regulations	Yes	0.5
FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use	Drug Regulatory Process; Drug Safety; Opioids	Yes	0.5
FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions	Drug Regulatory Process; Drug Development; Drug Safety	Yes	0.5
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)	Drug Regulatory Process; Drug Development; Drug Safety	Yes	0.5
FDA/CDER Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Evaluate the Effects of Intrinsic and Extrinsic Factors	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA's Biomarker Qualification Program	Drug Development	No	0
FDA's Overdose Prevention Framework with Dr. Marta Sokolowska	Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Opioids; Cancer Drugs	Yes	0.5
FDA's Regulation of Dietary Supplements with Dr. Cara Welch	Drug Development; Drug Regulatory Process; Drug Safety	Yes	0.5
FDA's Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond	Drug Regulatory Process	No	0
FDA's Work to Combat the COVID-19 Pandemic	COVID-19; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Frequently Asked Questions about Labeling for Prescription Medicines	Drug Regulatory Process; Drug Development; Drug Safety	Yes	1
GDUFA II Videos and Resources	Drug Development; Generic Drugs	No	0
Generics and Biosimilars	Biosimilars; Drug Regulatory Process; Drug Development; Generic Drugs	No	0
Generics-at-a-Glance with Dr. Sarah Ibrahim	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	Yes	0.5
Health Equity Forum Podcast	COVID-19; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health	No	0
Health Fraud Product Database	Drug Safety; Health Fraud	No	0
Health Fraud Scams	Drug Safety: Health Fraud	No	0
How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety	Drug Regulatory Process; Drug Safety	Yes	1
How to Avoid Medication Errors with Pen Injectors	Drug Safety; MedWatch	Yes	1
How to Use the Consumer Complaint System and MedWatch	Drug Safety; MedWatch	No	0
Hyperemesis Gravidarum: New Research and Insights	Women's Health; Drug Safety	Yes	1
Incorporating Biosimilars Into the Management of Patients With Immunological Conditions	Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women's Health	Yes	1
Increasing the Efficiency of Biosimilar Development Programs	Biosimilars;Drug Regulatory Process; Drug Development	No	0
Increasing the Efficiency of Biosimilar Development Programs 2023	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Information about Medications for Opioid Use Disorder (MOUD)	Drug Regulatory Process; Drug Safety; Opioids	No	0
Insanitary Conditions and Sterility Assurance	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	Yes	4
Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products	Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
Interchangeable Biological Products	Biosimilars	No	0
Interchangeable Biosimilars	Biosimilars	No	0
Investigations and Corrective and Preventive Actions (CAPA) 2023	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	Yes	5
Investigations and Corrective and Preventive Actions (CAPA) Virtual Course 2024	Compounding; Drug Regulatory Process; Drug Development	No	0
Joint US FDA - Health Canada ICH Public Meeting	Drug Development; Drug Regulatory Process; Drug Safety; IND/Expanded Access	No	0
Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes	Drug Safety	No	0
Maximizing Benefits and Minimizing Harms from Antibiotics	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch	No	0
Medical Extended Reality: Applications and Challenges	Drug Regulatory Process; Drug Development; Drug Safety	No	0
Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng	Drug Safety; MedWatch; Generic Drugs; Drug Regulatory Process, Health Fraud	Yes	0.5
MedWatch, Your Report Can Make a Difference with Dr. Gerald Dal Pan	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch	Yes	0.5
Minority Health and Health Equity Webinars	Drug Development; Drug Regulatory Process; Drug Safety, Minority Health	No	0
Naltrexone Injection for Opioid Use Disorder - FDA's Efforts to Reduce Medication Errors	Drug Regulatory Process; Drug Safety; MedWatch; Opioids	No	0
Navigating the World of Online Pharmacies with CDR Lysette Deshields	Drug Regulatory Process; Drug Safety; Health Fraud	Yes	0.5
OMHHE Health Equity Forum Podcast - Toward Improving Race and Ethnicity Data in Healthcare	Drug Development; Drug Regulatory Process	No	0
Oncology Drug Products Used with Certain In Vitro Diagnostic Tests: Pilot Program	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women's Health	No	0
Outsourcing Facility Guide	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	Yes	1.75
Overcoming Reluctance and Enhancing Biosimilar Adoption	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
Overcoming Reluctance and Enhancing Biosimilar Adoption (Medscape)	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	Yes	0.5
Overview of Expanded Access (EA) Program and EA eRequest Site	IND/Expanded Access; Rare Diseases; Drug Regulatory Process; Drug Development; Drug Safety	Yes	1
Overview of FDA role regulating and approving drugs	Drug Development; Drug Regulatory Process; Drug Safety; MedWatch	No	0
An Overview of FDA’s Project Facilitate Oncology Expanded Access Program	Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process	Yes	1
PCOS Revisited: Diagnosis, Management, and Future Needs	Women's Health; Drug Safety	Yes	1
Personnel Gowning in Sterile Drug Production	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	Yes	0.5
Pregnancy and Lactation Medication Information for the Healthcare Provider	Women's Health; Drug Regulatory Process; Drug Safety	Yes	1
Prescribe with Confidence	Drug Regulatory Process; Drug Safety; Opioids	No	0
Primary Care Providers Can Prescribe with Confidence	Drug Regulatory Process; Drug Safety; Opioids	No	0
Process Validation Virtual Course	Compounding; Drug Regulatory Process; Drug Development	Yes	15
Public meeting: FDA Rare Disease Day 2024	Drug Regulatory Process; Drug Safety Rare Diseases	Yes	4.75
Putting the Patient into Perspective: Strategies for Educating Patients about Biosimilars	Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women's Health	Yes	0.25
Q&A with FDA Podcast	COVID-19; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch	Yes	0.5
Quality Management Systems Virtual Course	Compounding; Drug Regulatory Process; Drug Development	Yes	15
Rare Diseases - Challenges and Progress in Drug Development	Drug Development; Drug Safety; Rare Diseases	Yes	1
READDI for the next pandemic	Drug Development; Drug Regulatory Process; Drug Safety	No	0
Regulatory Framework for Human Drug Compounding	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	Yes	1.5
Regulatory Science at CDER Videos	Drug Regulatory Process; Drug Development	No	0
Reporting and Public Viewing of Individual Case Safety Reports (ICSRs)	Drug Regulatory Process; Drug Development; Drug Safety; MedWatch	Yes	1
Reporting Unlawful Sales of Medical Products on the Internet	Drug Safety	No	0
Risk Evaluation and Mitigation Strategies (REMS) Program Part 1	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
Risk Evaluation and Mitigation Strategies (REMS) Program Part 2	Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs	No	0
Safe Opioid Disposal	Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; Cancer Drugs;Opioids	No	0
Safety Labeling Changes for Leukotriene Receptor Antagonists and Decisions Behind a Boxed Warning	Drug Regulatory Process; Drug Development; Drug Safety; MedWatch	Yes	1
SBIA Chronicles	Drug Regulatory Process	No	0
Second Annual FDA ASCO WORKSHOP on Getting the Dosage Right	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Stability and Beyond Use Dates	Case Study; Compounding; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch; Case Study	Yes	4
State of Outsourcing Facility Sector and Possibilities for the Future	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	No	0
A Step Forward in the Treatment of Opioid and Alcohol Dependence with Dr. Iilun Murphy and Dr. Marta Sokolowska	Drug Regulatory Process; Drug Safety; Generic Drugs; Opioids	Yes	0.5
Sterile Drug Compounding In-person Course	Compounding; Drug Regulatory Process; Drug Development	Yes	16
Sterility Testing: Common Misconceptions	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	Yes	0.75
Successes and Opportunities in Modeling and Simulation for FDA	Drug Development; Drug Regulatory Process	No	0
Summary Report for Biosimilars	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Supplier/Contractor Qualification and Management	Compounding; Drug Development; Drug Regulatory Process; Drug Safety	Yes	4
Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	Yes	0.5
The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein	Drug Regulatory Process; Drug Safety; OTC Drug Regulations	Yes	0.5
The FDA Bad Ad Program and Prescription Drug Promotion	Drug Regulatory Process; Drug Safety	No	0
The FDA Process for Approving Generic Drugs	Drug Regulatory Process; Drug Development; Generic Drugs	No	0
The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips	Drug Development; Drug Regulatory Process; Drug Safety; Suncreen	No	0
The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development	Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety	No	0
The Safety Evaluation and Surveillance of Generic Drugs	Generic Drugs; Drug Regulatory Process; Drug Development; Drug Safety	Yes	1.5
Topics in Public Health	Biosimilars; Cancer Drugs; Case Study; Compounding; COVID-19; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access; MedWatch; Opioids; OTC Drug Regulations; Women's Health	Yes	1
Treatment Using Medication for Opioid Use Disorder Can Save Lives	Drug Regulatory Process; Drug Safety; Opioids	No	0
Understanding Generic Narrow Therapeutic Index Drugs	Generic Drugs; Drug Regulatory Process; Drug Development; Drug Safety	Yes	1
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity	Drug Regulatory Process; Drug Development; Drug Safety	Yes	0.5
Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity	Drug Development; Drug Regulatory Process; Drug Safety; MedWatch	No	0
Using Bayesian Statistical Approaches to Advance our Ability to Evaluate Drug Products	Drug Development; Drug Regulatory Process; Drug Safety	No	0
What does FDA regulate?	Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; OTC Drug Regulations; Women's Health	No	0
What is a Biosimilar?	Biosimilars; Drug Regulatory Process; Drug Development	No	0
What is a Biosimilar? (Spanish)	Biosimilars; Drug Regulatory Process; Drug Development; Español	No	0
Where and How to Dispose of Unused Medicines	Drug Safety; Opioids	No	0
Why Does the FDA Exist?	Drug Development; Drug Regulatory Process; Drug Safety	No	0
FDA Drug Topics Webinars	Biosimilars; Cancer Drugs; Cannabidiol; Compounding; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Health Fraud; IND/Expanded Access; Opioids; Rare Diseases	Yes	1
FDA approvals of Augtyro (repotrectinib) and Krazati (adagrasib)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0
Real-World Data and Evidence Generation with Dr. Hilary Marston	Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence	No	0
Medicamentos biosimilares: Lo que los pacientes deben saber	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
What is Accelerated Approval?	Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety	No	0
How are Cancer Drugs Approved?	Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety	No	0
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause	Women's Health; Drug Safety	No	0
Curriculum Materials for Health Care Degree Programs | Biosimilars	Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety	No	0
FDA’s Role In Managing Drug Shortages	Drug Regulatory Process; Drug Safety	No	0
Sepa cuándo y cómo usar antibióticos	Drug Regulatory Process; Drug Safety; Español	No	0
OCE Conversations on Cancer, Cervical Cancer Treatment Innovation: A Collaborative Discussion	Cancer Drugs; Drug Development; Women's Health	No	0
FDA approval of Ryoncil (remestemcel-L-rknd)	Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety	No	0

---

Additional Resources

• FDA Drug Topics Webinars
• FDA Continuing Education Programs
• Training and Continuing Education
• FDA Learning Portal for Students, Academia, and Industry
• For questions contact CDER Division of Drug Information

 

Contact Us

Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993

druginfo@fda.hhs.gov

Toll Free

(855) 543-3784

(301) 796-3400

CDER Division of Drug Information

For Latest Updates Follow

@FDA_Drug_Info

Your source for the latest drug information.
Know the moment it happens.